Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based pharmaceutical firm Akorn has introduced Acetylcysteine Injection 6g/30mL in 30mL single-dose vials, which is an intravenous antidote indicted to treat acetaminophen overdose.
Subscribe to our email newsletter
Earlier in March, the company received approval of an abbreviated new drug application (ANDA) for the product from the US Food and Drug Administration (FDA)
The company’s product is therapeutically equivalent to Acetadote injection marketed by Cumberland Pharmaceuticals.
The product is available in a 6g/30mL (200mg/mL) concentration in 30mL single-dose vials.
For the twelve months ended 31 May 2015, branded and generic sales of Acetylcysteine Injection were about $29m, According to IMS Health.
The company is engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.
It produces ophthalmic, injectable and specialty non-sterile pharmaceuticals at its manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland and Paonta Sahib, India.